in

ClearOps Lands €8.6M to Build AI After-Sales OS

The big picture: ClearOps, a Munich-based enterprise SaaS startup building an AI-powered after-sales platform for industrial OEMs, closed an €8.6 million Series A funding round. Hitachi Ventures led the round, with participation from Schoeller Group and Barkawi Group. This marks the company’s first institutional capital raise.

Why it matters:

  • Industry Pressure: Industrial service networks face increasing pressure from connected machines, rising customer expectations for uptime, and global disruptions.
  • Profit Driver: After-sales is a major profit driver for OEMs and dealers, yet the industry largely relies on fragmented systems and manual procedures.
  • Real-time Operations: The future demands manufacturers and dealer networks that can predict, coordinate, and execute in real time to prevent downtime.

How it works:

  • Unified Platform: ClearOps connects OEMs, dealers, service partners, and machines on a single AI-powered platform without replacing existing infrastructure.
  • Data Orchestration: It aggregates and orchestrates data across the service supply chain, enabling predictive service operations and automated parts planning.
  • Proven Impact: The platform has increased parts availability by up to 40%, driven 5-15% growth in parts sales, and reduced repair times by up to two days for clients like AGCO, Terex, Jungheinrich, and Lippert.

The catch: The market for industrial after-sales AI solutions is competitive, with established ERP vendors and other specialized AI startups potentially developing similar capabilities. ClearOps’ success hinges on its ability to maintain a technological edge and rapidly scale its global go-to-market strategy against these entrenched players.

Key Facts

  • Company: ClearOps
  • Amount: €8.6 million
  • Round: Series A
  • Investors: Hitachi Ventures (lead), Schoeller Group, Barkawi Group
  • Founder: William Barkawi
  • Announced: 2026-05-21
  • Sector: Industrial AI
  • Headquarters: Munich
Dr. Ben K., Founder of siliXon.

siliXon Lands $1.5M to Design Circuit Boards

Dr Andrew Almond, Founder of Imperagen

Imperagen Lands €5.8M to Scale Enzyme Engineering